March 21, 2023 — Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and PathPresenter, the global image sharing platform for pathology, announced a collaboration to accelerate the enterprise adoption of digital pathology workflows.
The practice of pathology is undergoing a technology revolution, as laboratories and healthcare institutions move to equip pathologists with new digital tools to help improve patient outcomes, accelerate disease research, increase efficiency, and leverage promising new AI models. To drive ROI and future-proof their investment as they scale, institutions are seeking hardware and software solutions that are open format and truly interoperable.
The goal of this collaboration is to ensure a seamless user experience to the labs adopting Pramana’s Digital Pathology as a Service solution for whole slide image generation, as well as PathPresenter’s image management/image viewing platform. Through the cooperation, DICOM whole slide images created by Pramana have been validated for import and viewing via PathPresenter’s software, and both companies have committed to offer continued support and updates to take away the burden from the lab user.
“Pramana is fostering Digital Pathology 2.0 with its unique approach to bring rich software and algorithms inline with the image creation,” said Prasanth Perugupalli, Chief Product Officer of Pramana. “This allows enriched datasets to add significant value to the whole slide images, while also producing quality assurance parameters for building confidence for the lab technicians and pathologists. Our joint effort with PathPresenter will ensure that such enriched data is made available to the users in an industry standard format.”
“Delivering seamless interoperability and an excellent customer experience are key to enabling the broad adoption of digital pathology,” said Patrick Myles, CEO of PathPresenter. “Our collaboration with Pramana strengthens our collective goal of bringing practical digital workflows to the practice of pathology at enterprise scale.”
For more information: www.pathpresenter.com
January 20, 2026 
